快樂小藥師
- Dec 01 Wed 2010 06:22
你的802.11n有開通了嗎?
- Nov 30 Tue 2010 08:16
[Medscape]Pain Management -- Beyond the Basics: Intrathecal Drug Delivery
之前也有跟各位提過脊隨注射:
intrathecal 的藥物與用法
Case Presentation
A 61-year-old white man presents with a history of recent lower extremity pain.
The patient was diagnosed with multiple myeloma 26 months before admission and subsequently received multiple rounds of chemotherapy, including neurotoxic bortezomib and vincristine. He reports increasing bilateral lower extremity pain beginning roughly 6 months earlier, described as burning and numbing in nature. He also complains of severe sensitivity of the plantar aspect of his feet, making ambulation difficult. He has been evaluated by a neurologist and underwent an electromyographic (EMG) scan that demonstrates a mixed peripheral neuropathy and lumbar radiculopathy. Spinal magnetic resonance imaging (MRI) demonstrates multilevel lumbar degeneration. The neurosurgical consult states that the patient is not an operative candidate because of his diffuse disease. In addition, he has a history of cardiomyopathy.
- Nov 29 Mon 2010 06:58
[Micromedex][03]Acetylcysteine適應症整理
- Nov 28 Sun 2010 06:18
[Micromedex][02]Acetylcysteine適應症整理
- Nov 27 Sat 2010 06:48
[Micromedex][01] acetylcysteine 適應症整理
Acetylcysteine的功能很多,大家如果還有點印象,可以參考這邊:
- N-Acetyl-L-Cysteine 用於美白
- N acetylcysteine對Acetaminophen的中毒治療
- Acetaminophen與Acetylcysteine併用?
- 老藥新用:Acetylcysteine預防X光照相術顯影劑之腎毒性
之前也幫大家簡單整理過:
認識 N acetylcysteine
這次我就從幾個資料庫挑出他的適應症給大家參考:
- Nov 26 Fri 2010 08:15
[Nature Medicine]Inside the microbial and immune labyrinth: Totally gutted
- Nature Medicine Volume:16,Pages:1194–1195 Year published: (2010) DOI: doi:10.1038/nm1110-1194 Published online 04 November 2010
In Crohn's disease, immune damage to the gut wall is both induced and modified by the gut microflora, challenging researchers to solve the maze of interactions exploitable for therapeutic benefit. Whether these microbial 'guests' are worsening or helping in this scenario is still open to debate. In 'Bench to Bedside', Warren Strober highlights mice studies showing that certain microbes in the gut have a protective role promoting a shift towards an increased regulatory response that protects from recurrence of the disease. In 'Bedside to Bench', Thomas MacDonald examines how human studies using strategies to block soluble proinflammatory cytokines—despite solid supporting data from animal models—have shown disappointing results compared with therapies that neutralize soluble cytokines but also deplete proinflammatory cells, calling into question whether targeting a single soluble cytokine will ever be useful to treat people with Crohn's disease.
- Nov 25 Thu 2010 07:59
[Harrison][update]Hypertonic Fluids Not Beneficial in the Initial Treatment of Traumatic Brain Injury
Traumatic brain injury (TBI) is an unfortunately common cause of death and disability among people of all ages. In addition to the primary injury to the brain resulting from the initial impact, a variety of secondary injuries contribute to morbidity stemming in part from high intracranial pressure (ICP) and resultant reductions in cerebral perfusion, leading to ischemia. Therapy to minimize this secondary injury includes ICP management, and a recent trial (Bulger et al, 2010) examined whether rapid administration of hypertonic fluids, a well-known measure that reduces ICP, would lead to better outcomes in TBI patients.
- Nov 24 Wed 2010 07:54
[Goodman & Gilman's Pharmacology][update]Pediatric Pharmacotherapy Part 2: Pediatric Pharmacokinetics: Why Kids Are Not Small Adults
Marcel J. Casavant
Chief, Pharmacology-Toxicology, Nationwide Children's Hospital; Medical Director, Central Ohio Poison Center; Clinical Professor, The Ohio State University Colleges of Medicine and Pharmacy
Jill RK Griffith
Clinical Pharmacist, Mount Carmel West Hospital; Clinical Assistant Professor, The Ohio State University College of Pharmacy
- Nov 23 Tue 2010 06:36
如何用蘋果的鍵盤快速打出符號?
- Nov 22 Mon 2010 07:11
[Medscape]Propoxyphene Withdrawn From US Market
- Nov 21 Sun 2010 06:08
[WebMD]止痛藥物Propoxyphene的過量警告
美國食品藥物管理局(FDA)發布有關止痛藥propoxyphene的過量風險警告,這是一般銷售,並且以Darvon和Darvocet品牌名稱銷售。
- Nov 20 Sat 2010 06:27
Suile wound dressing 速癒樂敷料試用
上次有跟各位介紹過這個產品:Suile速瘉樂試用心得
- Nov 19 Fri 2010 07:06
Revlon beyond nature skin matching makeup 變色粉底試用
最近看到一個很有趣的粉底液,他和之前常用的粉底液不同,不需要很累的一個一個選顏色,只要挑接近你膚色系列的就可以了:
- Nov 18 Thu 2010 06:25
[NEJM]Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia
David J. Kuter, M.D., D.Phil., Mathias Rummel, M.D., Ralph Boccia, M.D., B. Gail Macik, M.D., Ingrid Pabinger, M.D., Dominik Selleslag, M.D., Francesco Rodeghiero, M.D., Beng H. Chong, M.D., Xuena Wang, Ph.D., and Dietmar P. Berger, M.D., Ph.D.
如果這個月都有看我的網誌,對這個藥就不陌生了:
[Drugs]Current and Future Management Options for Myelodysplastic Syndromes 骨髓發育不全症候群的治療與展望
Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura
紫斑症 Idiopathic Thrombocytopenic Purpura
- Nov 17 Wed 2010 09:26
windows XP 支援exFAT修正檔
- Nov 16 Tue 2010 07:19
[WebMD]EHA 2009: Romiplostim in Immune Thrombocytopenia Prevents Splenectomy (Romiplostim用於免疫性血小板缺乏 以預防脾臟切除)
- Nov 15 Mon 2010 05:58
[轉載]瑞士小孩不尖叫
引用於:http://www.hacken.cc/bbs/viewthread.php?tid=584053
裡面有圖解:
- Nov 13 Sat 2010 06:42
Vibativ (Telavancin Hydrochloride)
- Nov 12 Fri 2010 06:10
iressa 引起的甲溝炎
- Nov 10 Wed 2010 07:13
紫斑症 Idiopathic Thrombocytopenic Purpura
上次跟各位提過瘀青(喜療妥 hirudoid 試用),這次來講一個跟瘀青很類似,但是嚴重很多的疾病:紫斑症。
之前也有跟各位簡單介紹過:
Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura
- Nov 09 Tue 2010 06:39
Micromedex 2.0 簡單介紹
雖然說我對Micromedex的資料一直很有意見,但是不可否認的,他還是堪稱目前資料量最大的資料庫,而他最近也提供很多地方使用2.0的版本了,附帶一提,如果你有iphone等設備,也可以直接去下載2.0來用。
- Nov 07 Sun 2010 06:37
喜療妥 (喜療瘀) hirudoid 試用